GlassScriptPhysician profile
Winfred A Sardar
NPI 1952362824
$2,368.65
in general payments reported to CMS, 2019-2025
35 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $934 · 2020: $369 · 2021: $603 · 2022: $306 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $470.64 | 2019-2022 | |
| Nevro Corp. | $253.11 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $218.00 | 2019-2022 | |
| Amgen INC. | $173.63 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.36 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $106.64 | 2019-2025 | Ajovy |
| Pfizer INC. | $105.18 | 2019-2021 | |
| Abbvie INC. | $98.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $90.47 | 2019-2021 | |
| Tersera Therapeutics LLC | $61.08 | 2019 | |
| Almatica Pharma LLC | $58.68 | 2021 | |
| Medtronic, INC. | $42.16 | 2025 | Intellis Adaptivestim |
| Lundbeck LLC | $39.63 | 2021-2022 | |
| Eisai INC. | $38.82 | 2020-2021 | |
| Boston Scientific Corporation | $37.69 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $37.66 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.06 | 2025 | Entyvio |
| Upsher-Smith Laboratories LLC | $32.84 | 2019-2021 | |
| Redhill Biopharma INC. | $31.02 | 2021-2022 | |
| Assertio Therapeutics, INC. | $29.08 | 2019-2020 | |
| Emd Serono, INC. | $26.70 | 2025 | |
| Vertiflex, INC. | $25.63 | 2019 | |
| Si-Bone, INC. | $23.09 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.78 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.60 | 2019 | |
| Painteq LLC | $19.67 | 2021 | |
| Abbott Laboratories | $19.03 | 2019 | |
| Baudax Bio INC. | $17.57 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.97 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.74 | 2020 | |
| Mdd US Operations, LLC | $16.73 | 2019 | |
| Zyla Life Sciences, INC. | $16.43 | 2019 | |
| Lilly USA, LLC | $13.86 | 2020 | |
| Allergan, INC. | $13.26 | 2020 | |
| Horizon Therapeutics Plc | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winfred Sardar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.